- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05166434
Assessment Crestal Maxillary Sinus Membrane Elevation Using Different Implant Heights
Radiographic Assessment of Crestal Maxillary Sinus Membrane Elevation Using Different Dental Implant Heights in Atrophic Posterior Maxilla
Study Overview
Status
Intervention / Treatment
Detailed Description
For those patient who need up to 2-6 mm of vertical height, the 1-stage transcrestal osteotome technique shown to be stable over long term.
The most important negative factor that can be inferred from the results is that BAOSFE becomes less predictable when there is 4 mm or less of preexisting alveolar bone height beneath the sinus. Moreover, more challenging situation is the magnitude of tapping force, which may accidently perforate the antral membrane causing a lot of complication in the naso-antral apparatus by excessive taping force. The expansion of the osteotomy sites is performed with a number of Concave tipped tapered osteotomes with increasing diameters that are applied through the edentulous alveolar crest at the inferior border of the maxillary sinus floor. With each insertion of a larger osteotome, bone is compressed, pushed laterally and apically while pushing the garnered bone apically beneath the tented membrane.
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Contact
- Name: Maher mohammad Maqbol, BDS
- Phone Number: 0020 01141722802
- Email: maher.maqbol@dentistry.cu.edu
Study Locations
-
-
Giza
-
Cairo, Giza, Egypt, 11553
- Recruiting
- Maher Mohammed Hebah Maqbol
-
Contact:
- Mohammad m Khashaba, PHD
- Phone Number: 0020 01227754765
- Email: mohammedkhashaba@hotmail.com
-
Sub-Investigator:
- Mohammad m Atef, PHD
-
Principal Investigator:
- Mohammad m Khashaba
-
Sub-Investigator:
- Maher m Maqbol
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with edentulous vertically deficient posterior maxillary ridge a minimum 4 mm height of alveolar bone, and 6 mm in width.
- Both males as well as females without any active periodontal disease.
- All patients are in a good health with no systemic, immunologic or debilitating diseases that could affect normal bone healing.
- All selected patients are non-smokers and non-alcoholics.
- Patients are free from T.M.J troubles, abnormal oral habits such as bruxism.
- The edentulous ridges are covered with optimal thickness of mucoperiosteum with no signs of inflammation, ulceration or scar tissue.
- Remaining natural teeth have good periodontal tissue support and occlusion showed sufficient inter arch space for future prosthesis.
Exclusion Criteria:
- On the local level, patients with maxillary sinus diseases, former sinus surgery and unfavorable inter maxillary relationship will be excluded.
- General contraindications to implant surgery.
- Subjected to irradiation in the head and neck area less than 1 year before implantation.
- Untreated periodontitis.
- Poor oral hygiene and motivation.
- Uncontrolled diabetes.
- Pregnant or nursing.
- Substance abuse.
- Psychiatric problems or unrealistic expectations.
- Severe bruxism or clenching.
- Immunosuppressed or immunocompromised.
- Treated or under treatment with intravenous amino-bisphosphonates.
- Lack of opposite occluding dentition/prosthesis in the area intended for implant placement.
- Active infection or severe inflammation in the area intended for implant placement.
- Need of bone augmentation procedures at implant placement.
- Unable to open mouth sufficiently to accommodate the surgical tooling.
- Patients participating in other studies, if the present protocol could not be properly followed.
- Referred only for implant placement or unable to attend a 5-year follow-up.
- Requiring only single implant-supported crowns.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: bone formation around implant at 2mm membrane elevation crestal sinus lifting
|
this study will be divided in to three different groups, each group will receive a same technique of Crestal maxillary sinus lifting and implant placement at 2,4,6 mm heights.
Other Names:
|
|
ACTIVE_COMPARATOR: bone formation around implant at 4mm membrane elevation crestal sinus lifting
|
this study will be divided in to three different groups, each group will receive a same technique of Crestal maxillary sinus lifting and implant placement at 2,4,6 mm heights.
Other Names:
|
|
ACTIVE_COMPARATOR: bone formation around implant at 6mm membrane elevation crestal sinus lifting
|
this study will be divided in to three different groups, each group will receive a same technique of Crestal maxillary sinus lifting and implant placement at 2,4,6 mm heights.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measuring bone formation and density beyond apical part of dental implant after closed sinus lifting
Time Frame: 4 months after Dental implant placement
|
CBCT superimposition of the Pre-operative and Post-operative
|
4 months after Dental implant placement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measuring secondary stability of dental implants
Time Frame: 4 months after Dental implant placement
|
osttell device (ISQ)
|
4 months after Dental implant placement
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- o m f s 335
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Formation Around Implant After Crestal Sinus Lifting
-
Fayoum UniversityNot yet recruitingDental Implant | Sticky Bone | Sinus Lifting
-
Medical University of ViennaRecruitingDental Implant | Sinus Elevation | Bone FormationAustria
-
Ege UniversityCompletedVertical Alveolar Bone Loss | Implant Therapy | Sinus LiftingTurkey
Clinical Trials on trans-crestal sinus lifting
-
Al-Azhar UniversityCompleted
-
Delta University for Science and TechnologyMansoura UniversityCompleted
-
Hams Hamed AbdelrahmanUnknown
-
Cairo UniversityNot yet recruitingImplant Complication | Surgery-Complications | Sinus; Dental
-
Ain Shams UniversityNot yet recruitingInternal Sinus LiftingEgypt
-
VersahEnrolling by invitationSinus Floor Augmentation | Sinus InfectionUnited States
-
Tanta UniversityEnrolling by invitationMaxillary Sinus Augmentation Using CAD/CAM Allogenic Bone Blocks Versus Particulate Allogenic GraftsMaxillary Sinus | AllograftEgypt
-
Omar Saleh Ahmed BassedNot yet recruiting
-
Mansoura UniversityActive, not recruitingPartial Edentulism Class 2 Due to Periodontal DiseaseEgypt